| Grünenthal Pharma AG - Palexia 4 mg/ml, Lösung zum Einnehmen |
| 62841 | | 01 | | Palexia 4 mg/ml | | Lösung zum Einnehmen | | N02AX06 | | Tapentadol | | 25.07.2013 | | |
|
| Composition |
| tapentadolum 4 mg ut tapentadoli hydrochloridum 4.66 mg, acidum citricum monohydricum, sucralosum, aromatica (Himbeere) cum propylenglycolum 1.88 mg, aqua purificata, natrii benzoas (E211) 2.36 mg, ad solutionem pro 1 ml corresp. natrium 0.378 mg. |
| Packungsbestandteile |
| Solution (oral) | | | | | | Active Agent | Dose |
|---|
| Tapentadolum | 4 mg/ml |
| | | | Inactive agents | Dose |
|---|
| Citric Acid Monohydrate | | | Aqua Purificata | | | Aromatica (Himbeere) cum Propylenglycolum | 1.88 mg/ml | | Natrii Benzoas (E211) | 2.36 mg/ml | | Sucralosum | |
|
|
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 003 | 100 ml | PR | PR | A+ | | Yes |
|
